[1] Blomsterwall E, Bilting M, Stephensen H, et al. Gait abnormality is not the only motor disturbance in normal pressure hydrocephalus[J]. Scand J Rehabil Med, 1995, 27(4):205
[2] Klinge P, Hellstr?觟m P, Tans J, et al. One-year outcome in the European multicentre study on iNPH[J]. Acta Neurol Scand, 2012, 126(3):145
[3] Marmarou A, Bergsneider M, Klinge P, et al. The value of supplemental prognostic tests for the preoperative assessment of idiopathic normal-pressure hydrocephalus[J].Neurosurgery, 2005, 57(3 Suppl):S17
[4] Schirinzi T, Sancesario G M, Ialongo C, et al. A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus[J]. Front Neurol, 2015, 6:86
[5] Pfanner T, Henri-Bhargava A, BorchertS. Cerebrospinal fluid biomarkers as predictors of shunt response in idiopathic normal pressure hydrocephalus: a systematic review[J]. Can J Neurol Sci, 2018, 45(1):3
[6] Hellstr?觟m P, Klinge P, Tans J, et al. A new scale for assessment of severity and outcome in iNPH[J]. ActaNeurol Scand, 2012, 126(4):229
[7] Jingami N, Asada-Utsugi M, Uemura K, et al. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer’s disease[J]. JAD, 2015, 45(1): 109
[8] Luikku A J, Hall A, Nerg O, et al. Multimodal analysis to predict shunt surgery outcome of 284 patients with suspected idiopathic normal pressure hydrocephalus[J]. Acta Neurochir(Wien), 2016, 158(12):2311
[9] Hong Y J, Kim M J, Jeong E, et al. Preoperative biomarkers in patients with idiopathic normal pressure hydrocephalus showing a favorable shunt surgery outcome[J]. J Neurol Sci, 2018, 387:21
[10] Tarnaris A, Toma A K, Chapman M D, et al. Use of cerebrospinal fluid amyloid-β and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus[J]. J Neurosurg, 2011, 115(1):145
[11] Laitera T, Kurki M I, Pursiheimo J P, et al. The expression of transthyretin and amyloid-β protein precursor is altered in the brain of idiopathic normal pressure hydrocephalus patients[J]. J Alzheimers Dis, 2015, 48(4):959
[12] Patel S, Lee E B, Xie S X, et al. Phosphorylated tau/amyloid beta 1-42 ratio in ventricular cerebrospinal fluid reflects outcome in idiopathic normal pressure hydrocephalus[J]. Fluids Barriers CNS, 2012, 9(1):7
[13] Nakajima M, Miyajima M, Ogino I, et al. Cerebrospinal fluid biomarkers for prognosis of long-term cognitive treatment outcomes in patients with idiopathic normal pressure hydrocephalus[J]. J Neurol Sci, 2015,357(1/2):88
[14] Friede R L, Samorajski T. Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice[J]. Anat Rec, 1970,167(4):379
[15] Craven C L, Baudracco I, Zetterberg H, et al.The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus[J]. ActaNeurochir (Wien), 2017,159(12):2293
[16] Carmona-Calero E M, Gonzalez-Toledo J M, Castaneyra-Ruiz L, et al. Expression of aquaporin-1 in the choroid plexus in communicating and non-communicating hydrocephalic rats[J]. Eur J Anat, 2015, 19(2):125
[17] Blocher J, Eckert I, Elster J, et al. Aquaporins AQP1 and AQP4 in the cerebrospinal fluid of bacterial meningitis patients[J]. Neurosci Lett, 2011, 504(1):23
[18] Tarnaris A, Toma A K, Pullen E, et al. Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus[J]. Alzheimers Dement, 2011, 7(5):501
[19] Momjian S, Owler B K, Czosnyka Z, et al. Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus[J]. Brain, 2004, 127(Pt 5):965
[20] Nakajima M, Miyajima M, Ogino I, et al. Preoperative phosphorylated Tau concentration in the cerebrospinal fluid can predict cognitive function three years after shunt surgery in patients with idiopathic normal pressure hydrocephalus[J]. J Alzheimers Dis, 2018, 66(1):319
[21] Ray B, Reyes P F, Lahiri D K. Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau[J]. J Psychiatr Res, 2011,45(4):539
[22] Kitagaki H, Mori E, Ishii K, et al. CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry[J]. Am J Neuroradiol, 1998,19(7):1277
[23] Street J M, Barran P E, Mackay C L, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid[J]. J Transl Med, 2012,10:5
[24] Baird G, Montine T J, Chang J J, et al. Cerebrospinal fluid total Tau is increased in normal pressure hydrocephalus patients who undergo successful lumbar drain trials[J]. Cureus, 2017, 9(5):e1265